Arrowpoint Investment Partners »

Structure Therapeutics shares owned by Arrowpoint Investment Partners

Quarter-by-quarter ownership of Structure Therapeutics (GPCR) shares owned by Arrowpoint Investment Partners from 13F filings

Historical chart of Arrowpoint Investment Partners investment in Structure Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Structure Therapeutics held by Arrowpoint Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Structure Therapeutics by Arrowpoint Investment Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $202k 4.2k 48.20

More positions owned by Arrowpoint Investment Partners

Ishares Tr Expanded Tech Call Option (IGV)
Kraneshares Trust Csi Chi Internet (KWEB)
Alphabet Cap Stk Cl A (GOOGL)
Vaneck Etf Trust Semiconductr Etf Put Option (SMH)
Ishares Msci Brazil Etf Call Option (EWZ)
Ase Technology Hldg Sponsored Ads (ASX)
Ionis Pharmaceuticals (IONS)
Neurocrine Biosciences (NBIX)
Axsome Therapeutics (AXSM)
BioMarin Pharmaceutical (BMRN)
Ascendis Pharma A/s Sponsored Adr (ASND)
Ptc Therapeutics I (PTCT)
Pfizer (PFE)
Regeneron Pharmaceuticals (REGN)
Johnson & Johnson (JNJ)

View all positions for Arrowpoint Investment Partners

Top funds holding Structure Therapeutics

FMR
Wellington Management Company
venBio Select Advisor
Henderson Group
Deep Track Capital
BVF
Morgan Stanley
Principal Financial Group
Driehaus Capital Management
OrbiMed Advisors
American Century Companies
Baker Bros. Advisors
Siren
Casdin Capital
Capitolis Liquid Global Markets

View all funds holding Structure Therapeutics